Unknown

Dataset Information

0

Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine.


ABSTRACT: BACKGROUND/AIMS:Economic evaluation is integral to informed public health decision-making in the rapidly growing field of precision and personalized medicine (PM); however, this research requires specialized expertise and significant resources. Generic models are a novel innovation to efficiently address a critical PM evidence shortage and implementation barrier by enabling use of population-specific input values. This is a generic PM economic evaluation model proof-of-concept study for a pharmacogenomic use case. METHODS:An 8-step generic economic model development process was applied to the use case of human leukocyte antigen (HLA)-B*15:02genotyping for prediction of carbamazepine-induced cutaneous reactions, with a user-friendly decision-making tool relying on user-provided input values. This generic model was transparently documented and validated, including cross-validation comparing cost-effectiveness results with 3 country-specific models. RESULTS:A generic pharmacogenomic use case cost-effectiveness model with decision-making tool was successfully developed and cross-validated using input values for 6 populations which produced consistent results for HLA-B*15:02 screening at country-specific cost-effectiveness threshold values. Differences between the generic and country-specific model results were largely due to differences in model structure and assumptions. CONCLUSION:This proof on concept demonstrates the feasibility of generic models to provide useful PM economic evidence, supporting their use as a pragmatic and timely approach to address a growing need.

SUBMITTER: Snyder SR 

PROVIDER: S-EPMC6762029 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for Informed Decision-Making for Public Health Precision Medicine.

Snyder Susan R SR   Hao Jing J   Cavallari Larisa H LH   Geng Zhi Z   Elsey Amanda A   Johnson Julie A JA   Mohamed Zahurin Z   Chaiyakunapruk Nathorn N   Chong Huey Yi HY   Dahlui Maznah M   Shabaruddin Fatiha H FH   Patrinos George P GP   Mitropoulou Christina C   Williams Marc S MS  

Public health genomics 20180101 5-6


<h4>Background/aims</h4>Economic evaluation is integral to informed public health decision-making in the rapidly growing field of precision and personalized medicine (PM); however, this research requires specialized expertise and significant resources. Generic models are a novel innovation to efficiently address a critical PM evidence shortage and implementation barrier by enabling use of population-specific input values. This is a generic PM economic evaluation model proof-of-concept study for  ...[more]

Similar Datasets

| S-EPMC4223550 | biostudies-literature
| S-EPMC9148300 | biostudies-literature
| S-EPMC8703478 | biostudies-literature
| S-EPMC3305606 | biostudies-literature
| S-EPMC5129017 | biostudies-literature
| S-EPMC4046147 | biostudies-literature
| S-EPMC8652806 | biostudies-literature
| S-EPMC7946311 | biostudies-literature
| S-EPMC8361840 | biostudies-literature
| S-EPMC8391737 | biostudies-literature